🎯 Today's Healthcare Pulse
Quorum Health to transition to nonprofit status in $300M asset deal
Quorum Health, a private‑equity‑backed hospital operator, announced an asset‑only transaction with nonprofit Healthside Partners that will dissolve the for‑profit entity. The deal provides a $300 million capital‑investment plan and grants Quorum 340B drug‑discount eligibility and nonprofit tax benefits. The move aims to stabilize the financially strained hospital chain.
Also developing:
By the numbers: NervGen Pharma Corp. raises $60M in public offering
🚀 Top Healthcare Headlines
Senators Outline Plan For Medicare Home Care Benefit: What It Would Mean For Providers
A group of Democratic senators has unveiled a policy framework to establish a home care benefit within Medicare and expand Medicaid home- and community-based services, a “major policy shift” that was welcomed by home-based care organizations. The lawmakers’ framework, released on Wednesday, could improve access to care, increase efficiency, and create a more stable payment […] The post Senators Outline Plan For Medicare Home Care Benefit: What It Would Mean For Providers appeared first on Home Health Care News.
Home Health Care News
Digital Suppression of Women’s Health Info Is Affecting Real-World Outcomes – and Government Needs to Act
Ministers must recognise that design, moderation, and operational decisions taken by big tech firms are resulting in legitimate health advice for women being ‘shadowbanned’, according to Kate Prince from Essity […]
PublicTechnology.net (UK)
E&C Passes Wheelchair Access, ACO Digital Quality Bills
The House Energy & Commerce Committee passed unanimously Thursday (May 21) a bill that would create new Medicare billing codes for wheelchairs and another meant to reduce the administrative burden borne by providers enrolled in an accountable care organization (ACO). Tags: ACO DME Site Name: InsideHealthPolicy.com Author: Dorothy Mills-Gregg
Inside Health Policy
FDA Warns Public About Johnson & Johnson Heart Pump Controllers After Patient Death
The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025.
Cardiovascular Business
MicroLED Implant Could Cast New Light on Cancer Treatment
[](https://compoundsemiconductor.net/article/124267/MicroLED_implant_could_cast_new_light_on_cancer_treatment)
Compound Semiconductor
💰 Healthcare Fundraising
Efferon Secures €2.5M ($2.75M) Seed Round to Grow Blood‑purification Platform
Biotech firm Efferon closed a €2.5 million seed round led by private investors from the DACH region. The funding will support the European commercial rollout of its hemoadsorption device Efferon LPS and the construction of a new EU production facility, expanding manufacturing capacity for its sepsis therapy.
NervGen Pharma Corp. Prices $60M Public Offering of Shares and Warrants
NervGen Pharma Corp. announced the pricing of an underwritten public offering of 24 million common shares and up to 24 million warrants at $2.50 per share, targeting gross proceeds of about $60 million. Joint book‑running managers Leerink Partners and TD Cowen will lead the offering, which is expected to close on May 26 2026. Proceeds will fund the development of NVG‑291 and general corporate purposes.
💬 Top Healthcare Social Posts
UC San Diego Study Links Teen Cannabis Use to Persistent Cognitive Deficits
UC San Diego researchers announced that adolescent cannabis consumption is associated with measurable, long‑term deficits in cognitive development, marking the most extensive longitudinal evidence to date. Analyzing the first seven years of the ABCD Study—more than 11,000 children tracked since 2016—the team found that frequent users exhibited stagnant verbal‑memory scores and slower gains in attention, processing speed and visual‑spatial abilities compared with non‑using peers. ## New Evidence on Cognitive Growth "We were unique in our approach in that we use both toxicological testing and self‑report to do our cannabis‑use grouping," said Dr. Natasha Wade, assistant professor of psychiatry at UC San Diego School of Medicine. "Across the board, those who were using cannabis didn’t show the same level of cognitive growth. They were improving, but not at the same rate as their non‑using peers." The study leveraged hair‑based testing for carboxy‑THC, which captures frequent use over a three‑month window, allowing researchers to identify participants who used cannabis at least several times per month. Those identified showed the strongest correlation with reduced long‑term memory performance, and effect sizes were described as "large by typical statistical standards." The researchers caution that variations in dose, frequency and product type limit precise causal statements, but the consistency of the findings across multiple cognitive domains underscores a robust signal. The CDC reports that about one‑third of 12th‑grade students used cannabis in 2022, highlighting the relevance of these results for a sizable portion of the youth population. ## Policy Implications and Public Health Response Public‑health officials have long warned that adolescent cannabis exposure can alter brain development, but the new data provide concrete longitudinal metrics. "These results give us a clearer picture of how early exposure translates into measurable deficits that can affect academic performance and safety, such as driving," Wade added. The study’s release on April 20—coincidentally the cannabis‑culture holiday—has already prompted calls for updated school‑based education programs and tighter regulation of flavored vaping products that appeal to minors. State and local policymakers are likely to cite the findings as they debate age‑restriction laws and funding for prevention initiatives. The research also raises questions for clinicians who counsel families about substance use, suggesting that early screening and intervention could mitigate long‑term impacts. The UC San Diego team plans to continue monitoring the cohort through the study’s planned 10‑year endpoint, aiming to assess whether the observed deficits persist into adulthood or if remediation strategies can reverse them. Until then, the evidence adds weight to calls for a national conversation on teen cannabis use and its broader societal costs.
#stridesforaction #thegayagenda #fenwayhealth #lgbtqia #hivawareness #bostonpride | 💥 Katie Martell
The Gay Agenda is… universal healthcare, LGBTQ+ rights, AND raising money for lifesaving care while wearing sneakers. 🌈 This year, I’m proud to lead a Strides for Action team called THE GAY AGENDA (lol) in support of the incredible work of Fenway Health ! And because the gays can never simply attend an event… I’ll also be emceeing this year’s walk. Which means you can donate to a great cause AND hear me say inspirational things into a microphone before 10am. Strides for Action builds on the legacy of AIDS Walk Boston—a movement that reshaped HIV/AIDS funding, treatment, and awareness. For 40 years, this community has shown up for one another through the AIDS crisis, through political backlash, through grief, stigma, activism, and joy. That legacy matters. Especially now. Fenway Health provides affirming LGBTQIA+ healthcare, HIV prevention and treatment, mental health services, research, advocacy, and care for people who too often get left behind by the healthcare system. So yes, my team name is The Gay Agenda, which covers: ✔️ healthcare ✔️ dignity ✔️ science ✔️ community ✔️ JOY If you’ve got a few dollars to give towards this great cause, I’d deeply appreciate your support. Donate to my team, walk with us, or simply help spread the word. Because taking care of each other should never be controversial. https://lnkd.in/e3quVAgR #StridesForAction #TheGayAgenda #FenwayHealth #LGBTQIA #HIVAwareness #BostonPride
Thread by @Dougkessler
A world-class NIH Ebola lab in Maryland would have been springing into action right now, testing vaccines and treatments for this dangerous strain. Trump closed it along with the USAID resources that would have detected this outbreak weeks earlier. It’s not just stupid, it’s criminally stupid. Two words that sum up the man and his clown-car of an administration.